Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.9 DKK | +3.10% | -2.61% | +8.93% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 869M 6.05B | Sales 2025 * | 945M 6.58B | Capitalization | 1.83B 12.72B |
---|---|---|---|---|---|
Net income 2024 * | 72M 501M | Net income 2025 * | 86M 598M | EV / Sales 2024 * | 2.58 x |
Net Debt 2024 * | 412M 2.86B | Net Debt 2025 * | 383M 2.67B | EV / Sales 2025 * | 2.34 x |
P/E ratio 2024 * |
24.3
x | P/E ratio 2025 * |
20.4
x | Employees | 4,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.4% |
Latest transcript on Embla Medical hf.
1 day | +3.10% | ||
1 week | -2.61% | ||
Current month | -10.75% | ||
1 month | -8.28% | ||
3 months | +0.84% | ||
6 months | +15.89% | ||
Current year | +8.93% |
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 29.9 | +3.10% | 5,901 |
24-04-30 | 29 | -2.36% | 6,879 |
24-04-29 | 29.7 | +1.71% | 7,105 |
24-04-26 | 29.2 | 0.00% | 27,150 |
24-04-25 | 29.2 | -5.19% | 13,134 |
Delayed Quote Nasdaq Copenhagen, May 01, 2024 at 10:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.93% | 1.77B | |
-9.29% | 21.39B | |
-6.92% | 16.61B | |
+6.19% | 13.83B | |
+8.45% | 10.5B | |
-13.54% | 2.16B | |
+39.70% | 1.71B | |
+12.09% | 584M | |
-.--% | 423M | |
+29.81% | 132M |
- Stock Market
- Equities
- EMBLA Stock